Baylor Genetics

At the American Academy of Pediatrics (AAP) National Conference & Exhibition in San Diego, Lisa Salz, MS, CGC, will present two posters exploring the clinical utility of genome sequencing in pediatric care.

The research highlights how genome sequencing can uncover diagnoses that may be missed by other testing approaches and provide meaningful answers for children with complex genetic conditions.

Visit us at booth 1107 to connect with our team and learn how genome sequencing is informing diagnosis across a range of pediatric indications. Learn more: https://ow.ly/ECXU50ZU0Fj

Advances in healthcare, early intervention, and support have helped individuals with Down syndrome live longer, healthier lives than ever before.

During Down Syndrome Awareness Month, join us in recognizing the unique strengths, perspectives, and contributions of individuals with Down syndrome while celebrating the progress that continues to improve outcomes and quality of life.

Learn more about Down Syndrome: https://ndss.org/

What if genetic testing could help identify inherited cancer risk before symptoms appear?

Join us this Breast Cancer Awareness Month as we honor those impacted by breast cancer and highlight the role genetics can play in identifying inherited factors associated with breast cancer.

Genetic insights can help inform screening, risk management, and care decisions for patients and their families. At Baylor Genetics, we're committed to helping providers uncover hereditary risk through comprehensive genetic testing solutions that support earlier, more informed care.

Genomic sequencing continues to shape how neurological disorders are diagnosed and managed.

We're looking forward to sharing new research at the 55th Child Neurology Society (CNS) Annual Meeting, October 14-17, highlighting the impact of genome and exome sequencing in pediatric neurology.

Our team will present findings on genome sequencing utilization following expanded Medicaid coverage and the diagnostic utility of genome and exome sequencing for pediatric leukodystrophies and genetic leukoencephalopathies. Poster presentations will be led by Chad Moretz, ScD, Director of Health Economics & Outcomes Research, and Kayla Blankenship, MS, CGC, Clinical Science Liaison.

As an official genetic testing partner of the Child Neurology Society, Baylor Genetics is committed to advancing the use of genomics in clinical care.

Visit us at booth 500 to learn how our testing solutions support patients with complex neurological conditions. https://www.baylorgenetics.com/conferences/cns-2026/

When developmental delays began to raise questions, Lainey's family turned to Whole Genome Sequencing (WGS) for answers.

Within two weeks, WGS identified a rare CYFIP2 variant associated with Developmental and Epileptic Encephalopathy, helping connect Lainey to specialized care, tailored therapies, seizure monitoring, and a community of families facing similar challenges.

Today, Lainey's family has answers, access to the support she needs, and greater confidence in the road ahead.

Read Lainey's story: https://www.baylorgenetics.com/blog/laineys-story-how-whole-genome-sequencing-turned-uncertainty-into-answers/

Great conversations were on the agenda at our Whole Genome Sequencing (WGS) education dinner in Boston.

As the understanding of genetic disease continues to advance, access to comprehensive genomic testing is becoming increasingly important for identifying complex and rare conditions that may otherwise go undiagnosed.

Our group discussed how WGS and complementary genomic technologies can help provide a more complete picture, supporting earlier answers and more informed patient care. Thank you to everyone who joined us.

Learn how our integrated multiomic approach can support more informed clinical decisions and earlier answers for patients facing rare and complex conditions: www.baylorgenetics.com

Behind every diagnosis is a team dedicated to helping patients and providers navigate complex genetic information.

Join us in celebrating six members of our Clinical Indication team who recently achieved an important milestone. Hannah Mendoza, Brooklyn Stocksdale, Amy Kung, Joshua Truong, Lauren Cocozza, and Jordan Bruer recently earned their ABGC certification and are now certified genetic counselors.

Their achievement reflects the depth of expertise that helps patients, families, and providers navigate genetic testing with confidence.

Learn more about our patient-centered approach: https://www.baylorgenetics.com/about/

Today marks the start of World Mitochondrial Awareness Week! Join us in raising awareness of mitochondrial diseases and the individuals and families affected by them.

Mitochondrial diseases can impact multiple organ systems and present with a wide range of symptoms, often making diagnosis challenging. Increased awareness and access to advanced genetic testing can help support earlier answers and inform patient care.

At Baylor Genetics, we're committed to advancing research and supporting the mitochondrial disease community through every step of the diagnostic odyssey. Learn more about how we're expanding what's possible in precision diagnostics: www.baylorgenetics.com

Meet Sumit Kumar, VP of Financial Planning & Analysis at Baylor Genetics.

With extensive experience across global life sciences and technology organizations, Sumit leverages financial insights and strategic planning to provide the clarity needed for informed decision-making.

We are grateful to have Sumit on the Baylor Genetics team. His expertise in financial planning, analytics, and business transformation helps strengthen our ability to invest in innovation and advance our mission of delivering answers that matter.

Learn more about our team: https://www.baylorgenetics.com/people/